Substance / Medication

Sulbactam

Overview

Active Ingredient
sulbactam
RxNorm CUI
10167

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Research Evidence

Published studies and systematic reviews

Sort:
Population Pharmacokinetic Models of Ampicillin-Sulbactam Among Adult Patients with Infectious Diseases: A Systematic Review.
Poornachandran Mohananasunthari, Harun Sabariah Noor, Yin Teh Sin et al. · Ther Drug Monit · 2026
PMID: 40903201Meta-Analysis
Resistance ofComplex Clinical Isolates to Sulbactam-Durlobactam: A Systematic Review of Data from In Vitro Studies.
Falagas Matthew E, Romanos Laura T, Ragias Dimitrios et al. · Pathogens · 2025
PMID: 41156673Meta-AnalysisFull text (PMC)
Sulbactam-Durlobactam, A Novel Drug for the Treatment of Multidrug ResistantInfections - A Systematic Review.
Velmurugan Hemasri, Venkatesan Sajitha, Meles Hadush Negash et al. · Infect Disord Drug Targets · 2024
PMID: 38258766Meta-Analysis
Clinical Efficacy and Safety of Cefoperazone-Sulbactam in Treatment of Intra-Abdominal Infections: A Systematic Review and Meta-Analysis.
Lan Shao-Huan, Chao Chien-Ming, Chang Shen-Peng et al. · Surg Infect (Larchmt) · 2021
PMID: 33625294Meta-Analysis
Efficacy and safety of cefoperazone-sulbactam in empiric therapy for febrile neutropenia: A systemic review and meta-analysis.
Lan Shao-Huan, Chang Shen-Peng, Lai Chih-Cheng et al. · Medicine (Baltimore) · 2020
PMID: 32080150Meta-AnalysisFull text (PMC)
Efficacy of sulbactam for the treatment of Acinetobacter baumannii complex infection: A systematic review and meta-analysis.
Chen Haojun, Liu Qianqian, Chen Zhanguo et al. · J Infect Chemother · 2017
PMID: 28202329Meta-Analysis

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Sulbactam (substance)
SNOMED CT
96008003
UMLS CUI
C0038665
RxNorm CUI
10167

Clinical Data

This intervention maps to 7 entities in the Ltrl knowledge graph.

7
Conditions
0
Biomarkers
0
Specialists
0
Symptoms

Data is sourced from SNOMED CT, UMLS, and the Ltrl clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.